Press Release | Wed Mar 5, 2014 12:30pm EST

Bristol-Myers Squibb Presents Promising Phase IIb Data for Novel, Investigational Attachment Inhibitor for HIV-1 Infected Treatment-Experienced Patients

* Reuters is not responsible for the content in this press release.